Background: Targetoid hemosiderotic hemangioma is an uncommon, vascular, benign solitary lesion of lymphatic origin that can be misdiagnosed as other tumors including melanomas. Objectives: To evaluate the dermoscopic features of a large series of targetoid hemosiderotic hemangiomas. Methods: Digital dermoscopic images of 35 histopathologically confirmed cases of targetoid hemosiderotic hemangiomas collected from 7 hospitals in Spain and Italy were evaluated for the presence of dermoscopic structures and patterns. Results: The results of our study reveal that the presence of central red and dark lacunae and a peripheral circular reddish-violaceous homogeneous area is the most common dermoscopic pattern in targetoid hemosiderotic hemangioma (71.4%). The targetoid hemosiderotic hemangiomas of our study were correctly diagnosed in 77% of cases. Conclusion: Dermoscopy is helpful in improving the diagnosis of targetoid hemosiderotic hemangioma. However, attention must be paid to those cases that dermoscopically may show nontargetoid patterns, which often mimic other lesions, including melanoma.

Keywords:
Dermoscopy, Targetoid hemosiderotic hemangioma, Hobnail hemangioma
1.
Mentzel T, Partanen TA, Kutzner H: Hobnail hemangioma (‘targetoid hemosiderotic hemangioma'): clinicopathologic and immunohistochemical analysis of 62 cases. J Cutan Pathol 1999;26:279-286.
2.
Trindade F, Kutzner H, Tellechea Ó, Requena L, Colmenero I: Hobnail hemangioma reclassified as superficial lymphatic malformation: a study of 52 cases. J Am Acad Dermatol 2012;66:112-115.
3.
Sahin MT, Demir MA, Gunduz K, Ozturkcan S, Türel-Ermertcan A: Targetoid haemosiderotic haemangioma: dermoscopic monitoring of three cases and review of the literature. Clin Exp Dermatol 2005;30:672-676.
4.
Morales-Callaghan AM, Martinez-Garcia G, Aragoneses-Fraile H, Miranda-Romero A: Targetoid hemosiderotic hemangioma: clinical and dermoscopical findings. J Eur Acad Dermatol Venereol 2007;21:267-269.
5.
Ertam I, Akalin T, Unal I, Ozdemir F: Hobnail haemangioma: dermatoscopic findings facilitating the differential diagnosis. Clin Exp Dermatol 2009;34:e231-e233.
6.
Ghibaudo N, Lacour JP, Argenziano G, Ortonne JP, Bahadoran P: Fully regressive targetoid haemosiderotic haemangioma. J Eur Acad Dermatol Venereol 2009;23:722-723.
7.
Piccolo V, Russo T, Mascolo M, Staibano S, Baroni A: Dermoscopic misdiagnosis of melanoma in a patient with targetoid hemosiderotic hemangioma. J Am Acad Dermatol 2014;71:e179-e181.
8.
Zaballos P, Daufí C, Puig S, et al: Dermoscopy of solitary angiokeratomas: a morphological study. Arch Dermatol 2007;143:318-325.
9.
Marghoob AA, Cowell L, Kopf AW, Scope A: Observation of chrysalis structures with polarized dermoscopy. Arch Dermatol 2009;145:618.
10.
Moscarella E, Zalaudek I, Buccini P, Cota C, Catricalà C, Argenziano G: Dermoscopy and confocal microscopy of thrombosed hemangiomas. Arch Dermatol 2012;148:410.
11.
Scalvenzi M, De Natale F, Francia MG, Balato A: Dermoscopy of microvenular hemangioma: report of a case. Dermatology 2007;215:69-71.
12.
Mota A, Argenziano G, Zalaudek I, et al: Clinical, dermoscopic and histopathologic findings of retiform hemangioendothelioma. Dermatol Pract Concept 2013;31:11-14.
13.
Zaballos P, Puig S, Llambrich A, Malvehy J: Dermoscopy of dermatofibromas: a prospective morphological study of 412 cases. Arch Dermatol 2008;144:75-83.
14.
Zaballos P, Puig S, Malvehy J: Dermoscopy of pigmented purpuric dermatoses (lichen aureus): a useful tool for clinical diagnosis. Arch Dermatol 2004;140:1290-1291.
15.
Menzies SW, Kreusch J, Byth K, et al: Dermoscopic evaluation of amelanotic and hypomelanotic melanoma. Arch Dermatol 2008;144:1120-1127.
16.
Baroni A, Piccolo V: Images in clinical medicine: red melanoma. N Engl J Med 2013;368:1536.
17.
Carlson JA, Daulat S, Goodheart HP: Targetoid hemosiderotic hemangioma - a dynamic vascular tumor: report of 3 cases with episodic and cyclic changes and comparison with solitary angiokeratomas. J Am Acad Dermatol 1999;41:215-224.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.